Clinical predictors of successful magnetic resonance-guided focused ultrasound (MRgFUS) for uterine leiomyoma

BACKGROUND: Magnetic resonance-guided focused ultrasound (MRgFUS) is a relatively new minimally invasive treatment, approved by the US Food and Drug Administration in 2004 for treatments of symptomatic uterine leiomyomas (fibroids). The purpose of this work is to present retrospective cohort analysi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Ther Ultrasound
Päätekijät: Gorny, Krzysztof R, Borah, Bijan J, Weaver, Amy L, Brown, Douglas, Woodrum, David A, Stewart, Elizabeth A, Hesley, Gina K
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2013
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4265948/
https://ncbi.nlm.nih.gov/pubmed/25512860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-5736-1-15
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia